Literature DB >> 14715567

Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers.

Pratibha G Ray1, Shobhana D Kelkar.   

Abstract

Neutralizing antibody (NAb) responses to different rotavirus serotypes were compared in 64 convalescent-phase serum samples from hospitalized rotavirus-positive children less than 2 years of age and their mothers. Compared to the child patients, the mothers showed significantly higher NAb positivity to animal rotavirus serotypes G3 simian (96.88%), G6 bovine (85.94%), and G10 bovine (25.0%) and to human rotavirus serotypes G8 (79.69%) and G3 (57.81%) (P < 0.01 for each) but not to human serotypes G1, G2, G4, and G9 (P > 0.05). The overall prevalence of NAb among the child patients was low for human rotavirus serotypes G1 (20.31%) and G3 (21.8%). The comparative NAb response in individual mother-child paired serum samples was analyzed against each rotavirus serotype. A substantial number of child patients showed higher NAb titers than their mothers to serotypes G1, G2, G4, and G9, indicating that these serotypes are the major serotypes causing rotavirus diarrhea among the children of Pune, India. In these cases, the mothers were either negative or had lower titers of NAbs than their children. Correlation was observed between the infecting serotype and child patient serum that showed a homologous NAb response at a higher level than that of the mother. It appears that when the level of NAb to a particular serotype is higher among child patients than among their mothers, that serotype is the infecting serotype, and that low titers of NAb among the mothers predispose the children to infection with that serotype, if the serotype is in circulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715567      PMCID: PMC321334          DOI: 10.1128/cdli.11.1.186-194.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  58 in total

1.  Assay of neutralizing antibodies to animal rotavirus strains and human rotavirus serotype G8 by a modified method in the residents of Pune, India.

Authors:  S D Kelkar; P G Ray; S S Bedekar
Journal:  J Diarrhoeal Dis Res       Date:  1996-06

Review 2.  Rotavirus antigens.

Authors:  Y Hoshino; A Z Kapikian
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

Review 3.  Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children.

Authors:  A Z Kapikian; Y Hoshino; R M Chanock; I Pérez-Schael
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 4.  Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development.

Authors:  J R Gentsch; P A Woods; M Ramachandran; B K Das; J P Leite; A Alfieri; R Kumar; M K Bhan; R I Glass
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

5.  Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis.

Authors:  S Aijaz; K Gowda; H V Jagannath; R R Reddy; P P Maiya; R L Ward; H B Greenberg; M Raju; A Babu; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba.

Authors:  N A Cunliffe; W Dove; J E Bunn; M Ben Ramadam; J W Nyangao; R L Riveron; L E Cuevas; C A Hart
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

7.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

8.  Rotavirus infection in infants as protection against subsequent infections.

Authors:  F R Velázquez; D O Matson; J J Calva; L Guerrero; A L Morrow; S Carter-Campbell; R I Glass; M K Estes; L K Pickering; G M Ruiz-Palacios
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

9.  Homotypic immune response to primary infection with rotavirus serotype G1.

Authors:  A M Rojas; Y Boher; M J Guntiñas; I Pérez-Schael
Journal:  J Med Virol       Date:  1995-12       Impact factor: 2.327

10.  Neutralizing antibody immune response in children with primary and secondary rotavirus infections.

Authors:  C F Arias; S López; J D Mascarenhas; P Romero; P Cano; Y B Gabbay; R B de Freitas; A C Linhares
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
View more
  7 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.

Authors:  Sung-Sil Moon; Yuhuan Wang; Andi L Shane; Trang Nguyen; Pratima Ray; Penelope Dennehy; Luck Ju Baek; Umesh Parashar; Roger I Glass; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2010-10       Impact factor: 2.129

3.  Prevalence of rotavirus infection in children below two years presenting with diarrhea.

Authors:  B M John; Amit Devgan; Barnali Mitra
Journal:  Med J Armed Forces India       Date:  2014-04-03

4.  First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at all India Institute of Medical Sciences, New Delhi, India.

Authors:  Pratima Ray; S Sharma; R K Agarwal; K Longmei; J R Gentsch; V K Paul; R I Glass; M K Bhan
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 5.  Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.

Authors:  Sumit Sharma; Johan Nordgren
Journal:  Viruses       Date:  2021-06-14       Impact factor: 5.048

6.  Breastfeeding and the risk of rotavirus diarrhea in hospitalized infants in Uganda: a matched case control study.

Authors:  Eric Wobudeya; Hanifa Bachou; Charles K Karamagi; Joan N Kalyango; Edrisa Mutebi; Henry Wamani
Journal:  BMC Pediatr       Date:  2011-02-17       Impact factor: 2.125

7.  High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults.

Authors:  Julia Roider; Takashi Maehara; Abigail Ngoepe; Duran Ramsuran; Maximilian Muenchhoff; Emily Adland; Toby Aicher; Samuel W Kazer; Pieter Jooste; Farina Karim; Warren Kuhn; Alex K Shalek; Thumbi Ndung'u; Lynn Morris; Penny L Moore; Shiv Pillai; Henrik Kløverpris; Philip Goulder; Alasdair Leslie
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.